Stockreport

Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial

Psyence Biomedical Ltd. - Ordinary Shares  (PBM) 
PDF Patient screening underway; first patient expected to be randomized into the study in January A leading clinical trial site management organization (SMO), Australian Cl [Read more]